Background Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical course of sickle cell disease (SCD). Data on this important aspect of SCD have not yet been reported from West Africa. We investigated the relationship between HbF levels and the relevant genetic loci in 610 patients with SCD (98% HbSS homozygotes) from Cameroon, and compared the results to a well-characterized African-American cohort. Methods and Findings Socio-demographic and clinical features were collected and medical records reviewed. Only patients >5 years old, who had not received a blood transfusion or treatment with hydroxyurea were included. Hemoglobin electrophoresis and a full blood count were conducted upon arrival at the hospital. RFLP-PCR was used to describe the HBB gene haplotypes. SNaPshot PCR, Capillary electrophoresis and cycle sequencing were used for the genotyping of 10 selected SNPs. Genetic analysis was performed with PLINK software and statistical models in the statistical package R. Allele frequencies of relevant variants at BCL11A were similar to those detected in African Americans; although the relationships with Hb F were significant (p <.001), they explained substantially less of the variance in HbF than was observed among African Americans (~ 2% vs 10%). SNPs in HBS1L-MYB region (HMIP) likewise had a significant impact on HbF, however, we did not find an association between HbF and the variations in HBB cluster and OR51B5/6 locus on chromosome 11p, due in part to the virtual absence of the Senegal and Indian Arab haplotypes. We also found evidence that selected SNPs in HBS1L-MYB region (HMIP) and BCL11A affect both other hematological indices and rates of hospitalization. Conclusions This study has confirmed the associations of SNPs in BCL11A and HBS1L-MYB and fetal haemoglobin in Cameroonian SCA patients; hematological indices and hospitalization rates were also associated with specific allelic variants.
References
[1]
Bartolucci P, Galactéros F (2012) Clinical management of adult sickle-cell disease. Current Opinion in Hematology 19: 149–55. doi: 10.1097/moh.0b013e328351c35f
[2]
Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, et al. (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381: 142–51. doi: 10.1016/s0140-6736(12)61229-x
[3]
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, et al. (2011) Sickle cell disease in Africa: a neglected cause of early childhood mortality. American Journal of Preventive Medicine 41: S398–405. doi: 10.1016/j.amepre.2011.09.013
[4]
Weatherall DJ, Clegg JB (2001) Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 79: 704–12.
[5]
Wonkam A, Mba CZ, Mbanya D, Ngogang J, Ramesar R, et al. (2013) Psychosocial Burden of Sickle Cell Disease on Parents with an Affected Child in Cameroon. Journal of Genetic Counseling Jul 24. [Epub ahead of print]
[6]
World Bank (2010) Education for all-fast track initiative: support to the education sector. Report No. 48373-CM, 1–2.
[7]
Njamnshi AK, Mbong EN, Wonkam A, Ongolo-Zogo P, Djientcheu VD, et al. (2006) The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. Journal of the Neurological Sciences 250: 79–84. doi: 10.1016/j.jns.2006.07.003
[8]
Ruffieux N, Njamnshi AK, Wonkam A, Hauert CA, Chanal J, et al. (2013) Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children. Child Neuropsychology 19: 143–60. doi: 10.1080/09297049.2011.640932
[9]
Lettre G, Sankaran VG, Bezerra MA, Araújo AS, Uda M, et al. (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. . Proceedings of the National Academy of Sciences U S A. 105: 11869–74. doi: 10.1073/pnas.0804799105
[10]
Thein SL, Menzel S (2009) Discovering the genetics underlying foetal haemoglobin production in adults. British Journal of Haematology 145: 455–67. doi: 10.1111/j.1365-2141.2009.07650.x
[11]
Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, et al. (2012) Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 120: 1961–1962. doi: 10.1182/blood-2012-06-432849
[12]
Garner C, Tatu T, Reittie JE, Littlewood T, Darley J, et al. (2000) Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95: 342–6.
[13]
Solovieff N, Milton JN, Hartley SW, Sherva R, Sebastiani P, et al. (2010) Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5 olfactory receptor gene cluster. Blood115: 1815–1822. doi: 10.1182/blood-2009-08-239517
[14]
Thein SL, Menzel S, Peng X, Best S, Jiang J, et al. (2007) Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proceedings of the National Academy of Sciences U S A 104: 11346–11351. doi: 10.1073/pnas.0611393104
[15]
Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, et al. (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proceedings of the National Academy of Sciences U S A 105: 1620–1625. doi: 10.1073/pnas.0711566105
[16]
Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, et al. (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342: 253–7. doi: 10.1126/science.1242088
[17]
Platt OS (2008) Hydroxyurea for the treatment of sickle cell anemia. The New England Journal of Medicine 358: 1362–9. doi: 10.1056/nejmct0708272
[18]
Xu J, Peng C, Sankaran VG, Shao Z, Esrick EB, et al. (2011) Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334: 993–6. doi: 10.1126/science.1211053
[19]
Makani J, Menzel S, Nkya S, Cox SE, Drasar E, et al. (2011) Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 117: 1390–2. doi: 10.1182/blood-2010-08-302703
[20]
Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, et al. (1985) Common haplotype dependency of high G gamma-globin gene expressionand high HbF levels inbeta-thalassemia and sickle cell anemia patients. Proceedings of the National Academy of Sciences U S A 82: 2111–2114. doi: 10.1073/pnas.82.7.2111
[21]
Steinberg MH, Rosenstock W, Coleman MB, Adams JG, Platica O, et al. (1984) Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood. Jun 63(6): 1353–60.
[22]
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, et al. (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–4. doi: 10.1126/science.2999980
[23]
Steinberg MH, Lu ZH, Nagel RL, Venkataramani S, Milner PF, et al. (1998) Hematological effects of atypical and Cameroon beta-globin gene haplotypes in adult sickle cell anemia. American Journal of Hematology 59: 121–6. doi: 10.1002/(sici)1096-8652(199810)59:2<121::aid-ajh4>3.0.co;2-#
[24]
Pati N, Schowinsky V, Kokanovic O, Magnuson V, Ghosh S (2004) A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: accuracy, cost, and throughput. Journal of Biochemical and Biophysical Methods 60: 1–12. doi: 10.1016/j.jbbm.2003.11.005
[25]
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. The American Journal of Human Genetics 81: 559–575. doi: 10.1086/519795
[26]
Menzel S, Jiang J, Silver N, Gallagher J, Cunningham J, et al. (2007) The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans. Blood 110: 3624–3626. doi: 10.1182/blood-2007-05-093419
[27]
Ondei LS, Zamaro PJ, Mangonaro PH, Valêncio CR, Bonini-Domingos CR (2007) HPLC determination of hemoglobins to establish reference values with the aid of statistics and informatics. Genetics and molecular research 6: 453–60.
[28]
Creary LE, Ulug P, Menzel S, McKenzie CA, Hanchard NA, et al. (2009) Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS ONE 4: e4218. doi: 10.1371/journal.pone.0004218
[29]
Farrell JJ, Sherva RM, Chen ZY, Luo HY, Chu BF, et al. (2011) A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood 117: 4935–45. doi: 10.1182/blood-2010-11-317081
[30]
Elderdery AY, Mills J, Mohamed BA, Cooper AJ, Mohammed AO, et al. (2012) Molecular analysis of the B-globin gene cluster haplotypes in a Sudanese population with sickle cell anemia. International Journal of Laboratory Hematology 34: 262–266. doi: 10.1111/j.1751-553x.2011.01388.x
[31]
Hanchard N, Elzein A, Trafford C, Rockett K, Pinder M, et al. (2007) Classical sickle beta-globin haplotypes exhibit a high degree of long range haplotype similarity in African and Afro-Caribbean populations. BioMed Central Genetics 8: 52. doi: 10.1186/1471-2156-8-52
[32]
Bean CJ, Boulet SL, Yang G, Payne AB, Ghaji N, et al. (2013) Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia. British Journal of Haematology 163: 268–276. doi: 10.1111/bjh.12507
[33]
Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, et al. (1991) Pain in sickle cell disease. Rates and risk factors. The New England Journal of Medicine 325: 11–16. doi: 10.1056/nejm199107043250103
[34]
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, et al. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. The New England Journal of Medicine 330: 1639–1644. doi: 10.1056/nejm199406093302303
[35]
Galarneau G, Coady S, Garrett ME, Jeffries N, Puggal M, et al. (2013) Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients. Blood 122: 434–42. doi: 10.1182/blood-2013-01-478776
